- 全部删除
您的购物车当前为空
Trimetazidine是一种无关血流动力学的抗心绞痛剂,能够选择性地抑制mitochondrial enzyme 3-ketoacyl coenzyme A thiolase(LC 3-KAT)从而防止游离脂肪酸的β-氧化,IC50 值为 75 nM。Trimetazidine通过改变心脏代谢防止缺血再灌注损伤,具有抗氧化和抗缺血伤害的作用。

Trimetazidine是一种无关血流动力学的抗心绞痛剂,能够选择性地抑制mitochondrial enzyme 3-ketoacyl coenzyme A thiolase(LC 3-KAT)从而防止游离脂肪酸的β-氧化,IC50 值为 75 nM。Trimetazidine通过改变心脏代谢防止缺血再灌注损伤,具有抗氧化和抗缺血伤害的作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 127 | In stock | |
| 5 mg | ¥ 257 | In stock | |
| 10 mg | ¥ 413 | In stock | |
| 25 mg | ¥ 539 | In stock | |
| 50 mg | ¥ 662 | In stock | |
| 100 mg | ¥ 973 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 377 | In stock |
Trimetazidine 相关产品
| 产品描述 | Trimetazidine is a non-haemodynamic antianginal agent that selectively inhibits the mitochondrial enzyme 3-ketoacyl coenzyme A thiolase (LC 3-KAT), thereby preventing β-oxidation of free fatty acids, with an IC50 value of 75 nM. Trimetazidine prevents ischaemia-reperfusion injury by altering cardiac metabolism, exhibiting antioxidant and anti-ischaemic effects. |
| 靶点活性 | Long chain 3-ketoyl coenzyme A thiolase:75 nM |
| 体外活性 | 方法:Trimetazidine(50–200 μM,6小时)处理小鼠C2C12成肌细胞,使用CCK-8试剂测定细胞活力。 |
| 体内活性 | 方法:Trimetazidine(5 mg/kg,连续12天)腹腔注射给C26结肠癌小鼠,研究trimetazidine在癌症恶病质小鼠模型中的“运动模拟”作用。 |
| 别名 | 曲美他嗪 |
| 分子量 | 266.34 |
| 分子式 | C14H22N2O3 |
| CAS No. | 5011-34-7 |
| Smiles | COc1ccc(CN2CCNCC2)c(OC)c1OC |
| 密度 | 1.092 g/cm3 |
| 颜色 | White |
| 物理性状 | Viscous |
| 存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 85.00 mg/mL (319.14 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容